The potential role for sphingolipids in neuropathogenesis of Alzheimer’s disease

   
Alessenko A.V.1

1. N.M. Emanuel Institute of Biochemical Physics of the Russian Academy of Sciences
Section: Review
DOI: 10.18097/pbmc20135901025      PubMed Id: 23650721
Year: 2013  Volume: 59  Issue: 1  Pages: 25-50
The review discusses the functional role of sphingolipids in the pathogenesis of Alzheimer's disease. Certain evidence exist that the imbalance of sphingolipids such as sphingomyelin, ceramide, sphingosine, sphingosine-1-phosphate and galactosylceramide in the brain of animals and humans, in the cerebrospinal fluid and blood plasma of patients with Alzheimer's disease play a crucial role in neuronal function by regulating growth, differentiation and cell death in CNS. Activation of sphingomyelinase, which leads to the accumulation of the proapoptotic agent, ceramide, can be considered as a new mechanism for AD and may be a prerequisite for the treatment of this disease by using drugs that inhibit sphingomyelinase activity. The role of sphingolipids as biomarkers for the diagnosis of the early stage of Alzheimer's disease and monitoring the effectiveness of treatment with new drugs is discussed.
Download PDF:
Keywords: Alzheimer`s disease, sphingolipids (sphingomyelin, ceramide, sphingosine, sphingosine-1-phosphate, sulphatides), mass spectrometry of sphingolipids, brain, cerebrospinal fluid, blood plasma, biomarkers
Citation:

Alessenko, A. V. (2013). The potential role for sphingolipids in neuropathogenesis of Alzheimer’s disease. Biomeditsinskaya khimiya, 59(1), 25-50.
This paper is also available as the English translation: 10.1134/S1990750813020029
References  
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)